News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,859 Results
Type
Article (40202)
Company Profile (248)
Press Release (660409)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (204390)
Career Advice (2016)
Deals (35453)
Drug Delivery (97)
Drug Development (81692)
Employer Resources (172)
FDA (16367)
Job Trends (14870)
News (346304)
Policy (32726)
Tag
Academia (2560)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49515)
ALS (90)
Alzheimer's disease (1386)
Antibody-drug conjugate (ADC) (125)
Approvals (16369)
Artificial intelligence (255)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11648)
BIOSECURE Act (20)
Biosimilars (106)
Biotechnology (175)
Bladder cancer (80)
Brain cancer (27)
Breast cancer (280)
Cancer (2268)
Cardiovascular disease (185)
Career advice (1682)
Career pathing (30)
CAR-T (151)
Cell therapy (423)
Cervical cancer (19)
Clinical research (66547)
Collaboration (836)
Company closure (1)
Compensation (533)
Complete response letters (20)
COVID-19 (2601)
CRISPR (41)
C-suite (241)
Cystic fibrosis (100)
Data (2210)
Decentralized trials (2)
Denatured (18)
Depression (43)
Diabetes (274)
Diagnostics (6378)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (100)
Drug shortages (26)
Duchenne muscular dystrophy (93)
Earnings (86703)
Editorial (39)
Employer branding (21)
Employer resources (146)
Events (112592)
Executive appointments (722)
FDA (17630)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (749)
Gene editing (106)
Generative AI (19)
Gene therapy (302)
GLP-1 (740)
Government (4434)
Grass and pollen (4)
Guidances (67)
Healthcare (18861)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (118)
Indications (29)
Infectious disease (2745)
Inflammatory bowel disease (140)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (315)
IPO (16529)
IRA (40)
Job creations (3631)
Job search strategy (1428)
Kidney cancer (10)
Labor market (38)
Layoffs (471)
Leadership (17)
Legal (7937)
Liver cancer (76)
Lung cancer (321)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (307)
MASH (68)
Medical device (13388)
Medtech (13393)
Mergers & acquisitions (19470)
Metabolic disorders (701)
Multiple sclerosis (81)
NASH (21)
Neurodegenerative disease (92)
Neuropsychiatric disorders (27)
Neuroscience (1929)
NextGen: Class of 2025 (6526)
Non-profit (4487)
Now hiring (39)
Obesity (375)
Opinion (205)
Ovarian cancer (75)
Pain (87)
Pancreatic cancer (83)
Parkinson's disease (149)
Partnered (21)
Patents (234)
Patient recruitment (113)
Peanut (46)
People (57348)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20681)
Phase II (29299)
Phase III (21873)
Pipeline (1209)
Policy (140)
Postmarket research (2597)
Preclinical (8763)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (384)
Real estate (5908)
Recruiting (65)
Regulatory (22439)
Reports (46)
Research institute (2325)
Resumes & cover letters (351)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (70)
Series A (130)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (150)
Sponsored (29)
Startups (3579)
State (2)
Stomach cancer (13)
Supply chain (69)
Tariffs (40)
The Weekly (29)
Vaccines (691)
Venture capitalists (41)
Weight loss (246)
Women's health (35)
Worklife (16)
Date
Today (50)
Last 7 days (899)
Last 30 days (2580)
Last 365 days (32757)
2025 (10765)
2024 (35296)
2023 (40174)
2022 (51288)
2021 (55827)
2020 (54171)
2019 (46654)
2018 (35112)
2017 (32197)
2016 (31584)
2015 (37638)
2014 (31442)
2013 (26459)
2012 (28651)
2011 (29355)
2010 (27428)
Location
Africa (721)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (38191)
Australia (6245)
California (6137)
Canada (2017)
China (529)
Colorado (266)
Connecticut (275)
Delaware (148)
Europe (81750)
Florida (912)
Georgia (206)
Idaho (57)
Illinois (540)
India (25)
Indiana (309)
Iowa (11)
Japan (162)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (895)
Massachusetts (4571)
Michigan (220)
Minnesota (391)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1729)
New Mexico (28)
New York (1751)
North Carolina (969)
North Dakota (8)
Northern California (2682)
Ohio (204)
Oklahoma (14)
Oregon (35)
Pennsylvania (1377)
Puerto Rico (12)
Rhode Island (33)
South America (1098)
South Carolina (23)
South Dakota (1)
Southern California (2305)
Tennessee (101)
Texas (908)
United States (23150)
Utah (180)
Virginia (146)
Washington D.C. (62)
Washington State (551)
West Virginia (3)
Wisconsin (54)
700,859 Results for "anges mg inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Glenmark Pharmaceuticals Inc., USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product), 5 mg, 10 mg, 15 mg, 20 mg and 30 mg
April 17, 2025
·
3 min read
Press Releases
Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial
February 27, 2025
·
2 min read
Press Releases
Shorla Oncology Announces FDA Approval of TEPYLUTE® 100mg, First and Only Ready-to-Dilute Multi-Dose Vial of Thiotepa to Treat Breast and Ovarian Cancer and Commercial Launch of TEPYLUTE 15mg and 100mg Vials in the U.S.
April 29, 2025
·
12 min read
Press Releases
Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial)
April 2, 2025
·
2 min read
Press Releases
Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea
March 25, 2025
·
8 min read
Press Releases
Glenmark Pharmaceuticals Inc., USA launches Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL)
February 14, 2025
·
2 min read
Press Releases
Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials
March 4, 2025
·
2 min read
Press Releases
Glenmark Pharmaceuticals Inc., USA launches Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules
January 22, 2025
·
2 min read
Press Releases
Incyte and Syndax Announce U.S. Food and Drug Administration (FDA) Approval of Niktimvo™ (axatilimab-csfr) 9 mg and 22 mg Vial Sizes
January 15, 2025
·
14 min read
Press Releases
Regeneron Provides Update on EYLEA HD® (aflibercept) Injection 8 mg Supplemental Biologics License Application
April 21, 2025
·
11 min read
1 of 70,086
Next
